FDA Drug Application (022318) for RENVELA by GENZYME

Back to FDA Applications sponsored by GENZYME

Application Number022318
Product Number001
FormFOR SUSPENSION;ORAL
Dosage800MG/PACKET
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRENVELA
Active IngredientSEVELAMER CARBONATE



Back to FDA Applications sponsored by GENZYME